Oncogenic K-Ras mutation occurs frequently in several types of cancers including pancreatic and lung cancers. Tumors with K-Ras mutation are resistant to chemotherapeutic drugs as well as molecular targeting agents. Although numerous approaches are ongoing to find effective ways to treat these tumors, there are still no effective therapies for K-Ras mutant cancer patients. Here we report that K-Ras mutant cancers are more dependent on K-Ras in anchorage independent culture conditions than in monolayer culture conditions. In seeking to determine mechanisms that contribute to the K-Ras dependency in anchorage independent culture conditions, we discovered the involvement of Met in K-Ras-dependent, anchorage independent cell growth. The Met signaling pathway is enhanced and plays an indispensable role in anchorage independent growth even in cells in which Met is not amplified. Indeed, Met expression is elevated under anchorage-independent growth conditions and is regulated by K-Ras in a MAPK/ERK kinase (MEK)-dependent manner. Remarkably, in spite of a global down-regulation of mRNA translation during anchorage independent growth, we find that Met mRNA translation is specifically enhanced under these conditions. Importantly, ectopic expression of an active Met mutant rescues K-Ras ablation-derived growth suppression, indicating that K-Ras mediated Met expression drives "K-Ras addiction" in anchorage independent conditions. Our results indicate that enhanced Met expression and signaling is essential for on April 19, 2017.
Introduction
K-Ras mutations are frequently found in pancreatic, lung and colorectal tumors [1] [2] [3] . These mutations are predominantly somatic missense mutations at position 12, 13, or 61 that impair the GTPase activity of K-Ras and result in constitutive activation of downstream signaling pathways including the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) pathways. Even after three decades of research, many questions remain as to how mutant K-Ras contributes to tumor initiation and progression. There are currently no effective treatments for cancers with mutant K-Ras. Patients with K-Ras mutant tumors are associated with resistance to chemotherapy, radiation and epidermal growth factor receptor (EGFR) targeted therapies [4] [5] [6] [7] [8] , and tend to have poor overall survival [9] [10] [11] [12] . Numerous research efforts to develop therapeutic agents to directly inhibit oncogenic Ras have thus far been unsuccessful [13] , and the focus has therefore been on targeting druggable molecules in the pathways downstream of Ras. In this regard, combination therapies with mitogen-activated protein kinase kinase (MEK) and PI3K pathway inhibitors have been shown to be effective in mouse tumor models harboring mutant K-Ras [14] [15] [16] , and some combinations of these inhibitors are already in clinical trials.
Materials and Methods

Reagents and cell culture
PHA-665752, XL-184, MK2206, GSK-1120212 and BKM120 were from Selleckchem. Technologies) supplemented with 10% FBS and 500 U/mL Penicillin and 500 µg/mL Streptomycin.
To generate "Rasless" MEFs, 4-Hydroxytamoxifen (4-OHT) (Sigma) was used at a final conjugated to horseradish peroxidase (GE health care). Blots were visualized with an enhanced chemiluminescence system, according to the manufacturer's instructions (GE health care).
Real-time PCR
RNA was extracted with RNeasy mini kit using DNase I (Qiagen) 
Polysome fractionation and analysis of polysomal associated mRNA
Monolayer and anchorage-independent cell cultures were harvested 72hrs after plating and Enhanced MET translation and signaling sustains K-Ras driven proliferation under anchorageindependent growth conditions 12 incubated with 100 μg/ml cyclohexamide (Sigma) in PBS for 10 minutes on ice. Cells were pelleted and lysed in 10mM Tris-HCl pH8, 140 mM NaCl, 1.5mM MgCl 2 , 0.25% NP-40, 0.1% Triton-X 100, 50mM DTT, 150μg/ml cyclohexamide, 640U/ml RNasin for 30 minutes. Lysates were cleared by centrifugation for 5 minutes at 9,300 xg and loaded onto a 10-50% sucrose gradient. Loaded sucrose gradients were spun at 37,000 rpm for 2.5 hours at 4 o C in a Beckman L8-70M ultracentrifuge.
Sucrose gradients were then fractionated on an ISCO gradient fractionation system to assess polysome profiles and collect polysomal mRNA. RNA was isolated from gradient fractions using TRIzol Reagent (Invitrogen) and Pure Link RNA mini kits (Invitrogen) according to the manufacturer's protocol. Purified RNA was reverse-transcribed to cDNA using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems). cDNA samples were diluted 1:4 and 1ul of template was used in a SYBR green qPCR assay (Biorad) run on a MyiQ2 Real-Time PCR Detection System (Biorad) to determine Met mRNA expression relative to β-actin. The primer sets used were as follows: Met AGCGTCAACAGAGGGACCT and GCAGTGAACCTCCGACTGTATG; β-actin GCAAAGACCTGTACGCCAAC and AGTACTTGCGCTCAGGAGGA. Enhanced MET translation and signaling sustains K-Ras driven proliferation under anchorageindependent growth conditions
Statistical analysis
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All analyses for statistically significant differences were performed with the 2-tailed unpaired Student's t test. p-values less than 0.05 were considered significant. All error bars shown in the figures in this article are S.D.
Results
K-Ras mutant cell lines are more dependent on K-Ras in anchorage independent than in monolayer culture conditions
To understand the alterations of K-Ras dependencies in response to environmental changes in KRas mutant cancer cells, we first introduced a small interfering RNA (siRNA) targeting K-Ras to cells and cultured them in monolayer and anchorage independent culture conditions. Consistent with previous reports [17, 18] , in monolayer conditions, the growth of A549 and Panc1 cells was relatively resistant to KRas depletion, whereas Capan1 cell growth was decreased markedly upon K-Ras knockdown, reflecting the different degrees of K-Ras requirements among these cell lines in this culture condition. Interestingly, K-Ras depletion resulted in striking growth suppression in all three cell lines in anchorage independent culture conditions ( Fig. 1A and 1B) . To exclude the possibility of off-target effects of the siRNA, three additional siRNAs targeting different sequences of K-Ras were also used for proliferation assays and gave similar results (Supplementary Fig. 1 in cell proliferation in anchorage independent conditions. Met signaling is up-regulated in anchorage independent culture conditions To identify differences in the signaling profiles between monolayer and anchorage independent culture conditions, the expression and phosphorylation of several different signaling proteins were analyzed. Strikingly, compared to monolayer conditions, Met protein expression and phosphorylation was found to be up-regulated in anchorage independent conditions in several pancreatic, colorectal and lung cancer cell lines harboring mutant K-Ras ( Fig. 2A) . In addition, Met phosphorylation could be inhibited by addition of the Met specific inhibitor, PHA-665752, in line with the activation of Met signaling in anchorage independent culture conditions. Importantly, all of these cell lines were found to be more dependent on K-Ras for growth in anchorage independent culture conditions than monolayer conditions ( Supplementary Fig. 2 ).
To exclude the possibility that the increase in Met in anchorage independent conditions is caused by the selection of cells with higher Met expression, we cultured cells in anchorage independent conditions for 3 days, and then switched them to monolayer conditions and incubated for an additional 2 days. Met protein levels significantly increased after 3 days of anchorage independent culture, and decreased after an In tumors, Met signaling can be enhanced by increased Met expression, activating Met mutations or HGF overexpression. The main source of HGF is not thought to be the cancer cells themselves but instead the surrounding stroma [27] . In line with this, HGF mRNA or HGF protein expression was below detection levels in Capan1 and Suit2 cells (data not shown). Therefore, in order to further explore the significance of Met signaling pathways, we next stimulated cells with recombinant human HGF in monolayer and anchorage independent culture conditions. Stimulation of the cells with human HGF resulted in the phosphorylation of Met in both conditions (Fig. 3F) . However, the degree of HGF-induced Met phosphorylation was significantly higher in anchorage independent culture conditions than in monolayer culture conditions (Fig. 3F) . Consistent with these results, HGF promoted proliferation of cells cultured in anchorage independent culture conditions significantly more than in monolayer conditions ( Fig. 3B and 3C) , consistent with the observation that EGFR levels were identical between the two conditions (Fig. 2B) . Together, these observations strongly suggest that HGF/Met signaling contributes to K-Ras-dependent cell proliferation specifically in anchorage independent culture conditions.
K-Ras/MEK signaling regulates Met expression
Our results demonstrate that both K-Ras and Met play an essential role in anchorage independent cell growth of K-Ras mutant cancer cells. Although K-Ras is a known effector of Met, other mechanisms linking K-Ras and Met signaling may play a role in anchorage independent cell growth. To examine the relationship between K-Ras and Met we knocked down either K-Ras or Met and examined their effects on the expression of each other. As shown in Fig. 4A , K-Ras ablation resulted in the down-regulation of Met protein and phosphorylation levels both in monolayer and anchorage independent culture conditions. In contrast, knockdown of Met did not affect K-Ras protein expression (Fig. 3C) . These results suggest that K-Ras regulates Met expression.
To assess the effect of K-Ras activity on Met expression, we focused our analysis on pancreatic cancer cell lines harboring mutant K-Ras (Suit2: G12D and Capan1: G12V) or wild-type K-Ras (BxPC3). (Fig. 4C) . Moreover, analysis of human patient samples demonstrated that pancreatic cancers with mutant K-Ras also express higher levels of Met mRNA than those with wild-type K-Ras (Fig. 4D ).
To further investigate the role of K-Ras on Met expression, we used "Rasless" MEFs completely devoid of all three Ras isoforms (H-, N-, and K-Ras) and re-introduced exogenous wild-type or mutant (G12D or G12V) forms of K-Ras. Ectopic expression of either wild-type or mutant K-Ras in the Rasless cells elevated Met protein levels (Fig. 4E) . Interestingly, MEFs ectopically expressing K-Ras, but not Rasless MEFs, enhanced Met phosphorylation levels drastically after HGF stimulation (Fig. 4E) . Together, these findings strongly suggest that K-Ras-driven signaling is essential for Met expression and function.
To identify intermediaries in the K-Ras/Met axis, cells were incubated with small molecule kinase inhibitors targeting Akt (MK2206), MEK1/2 (GSK 1120212) and/or PI3K (BKM120). Only inhibition of MEK1/2 significantly decreased Met protein levels, indicating that K-Ras-driven MEK signaling is responsible for Met expression (Fig. 4F) . In addition, qPCR analysis revealed that K-Ras knockdown or MEK inhibitor treatment decreased Met mRNA expression (Fig. 4G) . Moreover, cells were more sensitive to MEK1/2 inhibition in anchorage independent culture conditions than in monolayer conditions, Supplementary   Fig. 4) . Collectively, these results demonstrate that the K-Ras/MEK signaling pathway positively regulates Met mRNA levels.
Ectopic expression of active Met rescues K-Ras ablation-induced growth suppression
Our observations that cells with mutant K-Ras required both K-Ras and Met for proliferation in anchorage-independent conditions and that K-Ras/MEK signaling positively regulated Met expression prompted us to examine the biological significance of crosstalk between these two pathways. To directly evaluate the role of Met in K-Ras mutant cancer cells, a lentiviral system was used to express a constitutively active M1268T Met mutant. The M1268T mutation in Met was originally identified in papillary renal carcinomas and is reported to cause enhanced Met phosphorylation and activation [28, 31] .
Met(M1268T) expression increased basal phosphorylation levels of Met and partially restored the phosphorylation levels of Met and Akt after K-Ras knock-down in Capan1 cells (Fig. 5A) . Importantly, expression of Met(M1268T) promoted the growth of K-Ras depleted cells only in anchorage independent culture conditions (Fig. 5B) . Similar results were obtained using A549 cells (Supplementary Fig. 5 ). This data suggests that K-Ras mediated Met expression contributes to K-Ras mediated cell proliferation in anchorage independent culture conditions. 
Enhanced MET translation and signaling sustains K-Ras driven proliferation under anchorageindependent growth conditions
Met translation is specifically enhanced in anchorage independent culture conditions Although K-Ras and Met contributed to cell proliferation more in anchorage independent culture conditions than in monolayer culture conditions, knock-down of K-Ras decreased Met protein levels both in anchorage independent and monolayer culture conditions (Fig. 4A) , indicating that K-Ras/MEKmediated regulation of Met mRNA expression does not change between these two conditions. To understand the mechanism by which Met protein levels increase specifically in anchorage independent conditions, we first tested whether the half-life of Met protein is altered between the two culture conditions. Capan1 and Suit2 cells were cultured in anchorage independent or monolayer conditions for 3 days, and then de novo protein synthesis was inhibited with cycloheximide (CHX). Immunoblot analysis at different time points after CHX treatment showed similar profiles for Met half-life in anchorage independent and monolayer culture conditions, indicating that anchorage independent culture does not alter the turnover of Met protein (Supplementary Fig.6A ). Furthermore, qPCR analysis showed no difference in Met mRNA levels between cells cultured in anchorage independent or monolayer conditions (Fig. 4G ).
Previous reports indicated that Met expression could be positively regulated by cap-dependent translation through increased expression of the cap-binding protein eIF4E [32] . Therefore, in order to test the possibility that cap-dependent Met translation is enhanced during anchorage-independent culture, we assessed the effect of anchorage-independent conditions on both global mRNA translation as well as Met (Fig. 6A) . Remarkably, however, we found that Met mRNA translation was instead enhanced under anchorage-independent growth conditions, as revealed by a shift in Met mRNA association towards more actively translating polysomal fractions ( Fig. 6B and Supplementary Fig. 6B ). As enhanced Met translation has previously been attributed to increased eIF4E expression, we next evaluated mRNA expression levels of the eIF4F components, eIF4E, eIF4G1, eIF4G3 and eIF4G2. Despite enhanced Met translation in anchorage-independent growth conditions, we found that eIF4E mRNA levels were unaffected by culture conditions, although there was an increase in eIF4G3 expression (Supplementary Fig. 6C ). Consistent with previous work [32], we found that inhibition of eIF4E-dependent translation with the small molecule 4EGI-1 decreased Met protein levels. However, the decrease was more significant in cells cultured in monolayer conditions, indicating that Met expression is less dependent on eIF4E when cells are cultured in anchorage independent conditions (Fig. 6C) . These results suggest that Met translation is specifically increased in cells cultured in anchorage independent conditions, perhaps in part through cap-independent mechanisms, to sustain higher Met protein levels necessary for anchorage-independent growth. Together, our data support a model in which mutant K-Ras contributes to Met expression, which is increased in anchorage independent culture conditions via increased translation, causing increased Metdriven proliferation and a stronger dependence on K-Ras. 
Discussion
The ability of cells to grow in anchorage independent and sphere forming culture conditions is known to reflect some characteristics of tumor cells, including self-renewal ability [25, 33] . Thus, in many cases, anchorage independent cell culture may be a better model for cancer studies. Here we have demonstrated that cancer cells with active K-Ras mutations are more dependent on K-Ras driven signaling in anchorage independent culture than in monolayer culture (Fig. 1A) . In investigating the mechanisms for this distinction in K-Ras dependency, we discovered that Met plays a pivotal role in anchorage independent conditions, potentially acting upstream of the Akt pathway (Fig. 5A) . Met translation and activation were increased when cells were cultured in anchorage independent conditions (Fig. 2) , leading to a stronger dependence of cells for Met, as seen by attenuated cell proliferation upon Met knock-down or Met inhibitor treatment (Fig. 3) . Furthermore, we found Met expression levels to be dependent on K-Ras/MEK signaling (Fig. 4) .
Although we could not detect HGF expression in our cancer cells lines (data not shown), we observed an increase in phospho-Met levels in anchorage independent culture conditions (Fig. 2) . RTKs such as Met are known to transduce signals in the absence of their ligands by phosphorylating each other when overexpressed, which is likely the cause for the increase in phospho-Met levels in this study. The impact of Met knock-down or Met inhibition on cell proliferation was smaller than the impact of K-Ras Thus, in anchorage independent culture conditions, the depletion of K-Ras leads to down regulation of Met mRNA and subsequent growth suppression (Fig. 7) .
The discovery of drugs that are effective against K-Ras mutant cancers is critical. Current initiatives to develop therapeutic agents to directly inhibit Ras are ongoing, and initiatives to inhibit 
